24.02.2025 • NewsNouryoninvestmentChromatography

Nouryon Doubles Capacity of Chromatography Media in Sweden

Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.

According to Nouryon, its chromatography media, a key product in the company's Consumer & Life Sciences segment, are used for purifying novel peptide-based pharmaceuticals, including treatments for type 2 diabetes and obesity.

“The rapidly growing demand for peptide-based drugs, driven by the rising prevalence of diabetes and obesity, requires a robust and reliable supply chain to ensure that patients around the world have access to the medications they need to lead healthier lives,” said Larry Ryan, president at Nouryon.

Suzanne Carroll, senior vice president of Consumer & Life Sciences at Nouryon, commented: “This expansion will enable us to continue as a leading supplier of high-quality silica-based chromatography media for active pharma ingredients.”

© BGStock72 – stock.adobe.com
© BGStock72 – stock.adobe.com

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.